| | 1 | = LhARA pre-CDR Meeting 10th Dec 2019 = |
| | 2 | |
| | 3 | == Meeting details == |
| | 4 | |
| | 5 | 14:00 Room 532, Blackett Lab. |
| | 6 | |
| | 7 | Zoom details: |
| | 8 | |
| | 9 | Join Zoom Meeting https://ukri.zoom.us/j/865262978 |
| | 10 | |
| | 11 | Phone one-tap: |
| | 12 | United Kingdom: +442034815237!,,865262978# or +442039663809!,,865262978# |
| | 13 | |
| | 14 | Join by Telephone For higher quality, dial a number based on your current location. |
| | 15 | United Kingdom: |
| | 16 | +44 203 481 5237\\ |
| | 17 | +44 203 966 3809\\ |
| | 18 | +44 131 460 1196\\ |
| | 19 | +44 203 051 2874 |
| | 20 | Meeting ID: 865 262 978 |
| | 21 | |
| | 22 | Join from an H.323/SIP room system H.323: 162.255.37.11 (US West) 162.255.36.11 (US East) 221.122.88.195 (China) 115.114.131.7 (India) 213.19.144.110 (EMEA) 103.122.166.55 (Australia) 209.9.211.110 (Hong Kong) 64.211.144.160 (Brazil) 69.174.57.160 (Canada) 207.226.132.110 (Japan) |
| | 23 | Meeting ID: 865 262 978 |
| | 24 | |
| | 25 | |
| | 26 | International numbers https://ukri.zoom.us/u/ap9aBI2Eh |
| | 27 | |
| | 28 | SIP: 865262978@zoomcrc.com \\ |
| | 29 | Skype for Business (Lync) https://ukri.zoom.us/skype/865262978 \\ |
| | 30 | Skype on a SurfaceHub SIP: 865262978@lync.zoom.us https://ukri.zoom.us/skype/865262978 |
| | 31 | |
| | 32 | |
| | 33 | == Agenda == |
| | 34 | * Action items from last meeting. |
| | 35 | * AK to note the instrumentation requirements for the definition of the baseline. |
| | 36 | * OE to circulate the blank risk assessment form. |
| | 37 | * AK to arrange meeting to discuss the laser target interface. |
| | 38 | * JPar to look into spot scanning beam specs for in vivo experiments. |
| | 39 | * AK to prepare abstract for upcoming abstract deadlines. |
| | 40 | * AK to ask Simon for a repository to store the simulation input files. |
| | 41 | |
| | 42 | |
| | 43 | |
| | 44 | * System updates. |
| | 45 | * Laser driven proton and ion source. |
| | 46 | * Proton and ion capture. |
| | 47 | * Stage 1 beam transport: Beam transport and delivery to the in vitro end station. |
| | 48 | * Stage 2 beam transport: Post-acceleration and beam delivery to the in vivo end station. |
| | 49 | * Biological end stations. |
| | 50 | * Infrastructure and Integration. |
| | 51 | * Project plan for the delivery of LhARA. |
| | 52 | * Safety. |
| | 53 | * End-to-end simulation. |
| | 54 | * Instrumentation. |
| | 55 | * A.O.B. |
| | 56 | * Plenary meeting talks. |
| | 57 | |
| | 58 | == Notes == |
| | 59 | Participants: |
| | 60 | Apologies: |
| | 61 | |
| | 62 | == Action Items == |
